• 

  Covid: What triggered China's deadly wave and should the world worry?

  World | December 22, 2022 21:32 IST

  China Covid Wave: Experts are of the view that the efficacy of the Chinese-home-made vaccines are not up to the level of foreign-made mRNA vaccines, as the former provide only 50 per cent efficacy.

• 

  Serum Institute seeks drug regulator's approval for market authorisation of Covovax as booster dose

  India | December 25, 2022 13:54 IST

  Covid-19: Earlier on October 17, Prakash Kumar Singh, director of government and regulatory affairs at SII, submitted a market authorization application to the Drug Controller General of India (DCGI) for the heterologous booster dose of Covovax.

• 

  OPINION | Covid: India on full alert, China is hiding facts about pandemic

  India | December 23, 2022 6:18 IST

  The pandemic is spreading in China, US, Japan, France, Brazil, South Korea and Germany. There are 2.43 crore active Covid-19 cases at present across the world, out of which India accounts for only 3,408.

• 

  Covid-19: Govt mulls mandating forms with RT-PCR, vaccination details for air travellers from abroad

  India | December 22, 2022 16:15 IST

  Covid-19: According to reports, the ministry will take a decision on it after examining the situation for the next few weeks.

• 

  Don't ignore flu symptoms, it could be Omicron: All about BF.7 sub-variant triggering Covid fears

  Health | December 22, 2022 10:33 IST

  COVID-19 in India: Omicron sub-variant BA.7 is the most infections so far since it is highly transmissible, has a shorter incubation period, and a higher capacity to cause reinfection or infect even those vaccinated.

• 

  Aaj Ki Baat: Full episode, December 21, 2022

  December 21, 2022 23:48 IST

  Hello and welcome to Aaj Ki Baat With Rajat Sharma, the only news show with real facts and no noise.

• 

  All hypotheses on Covid origin remain on table, will continue to call China to share data: WHO

  World | December 22, 2022 6:13 IST

  China Covid Blast: We continue to call on China to share the data and conduct the studies we have requested, and which we continue to request. As I have said many times before, all hypotheses about the origins of Covid19 pandemic remain on the table, WHO Director said.

• 

  New Covid Wave: How India's situation will be better than China? Ex-AIIMS Director explains

  India | December 22, 2022 6:13 IST

  China Covid Wave: As Covid cases are rising in China, India is on alert, with Centre giving new directions to health bodies to pep up Covid appropriate behaviour and conducting genome sequencing to identify the sub-variant of the virus.

• 

  China Covid Wave: How infectious is new Omicron BF.7 sub-variant and its symptoms

  India | December 21, 2022 21:07 IST

  China Covid wave: The new Omicron sub-variant is more infectious than previous variants. A person infected with BF.7 variant can infect 10 to 18 people.

• 

  Opinion | India on full alert after fresh outbreak of Covid in China

  India | December 22, 2022 6:13 IST

  At a high-level review meeting on Wednesday, Union Health Minister Mansukh Mandaviya chalked out a strategy to tackle the emerging crisis.

• 

  Karnataka govt issues advisory after detection of new COVID sub-variants in Maharashtra

  India | October 26, 2022 12:59 IST

  In view of the detection of newer sub-variants of Coronavirus, the Karnataka government has issued an advisory urging people to follow COVID appropriate behaviour and isolate themselves if they test positive for the virus.

Advertisement
• 

  Maharashtra reports 18 cases of XBB sub-variant of Omicron in 15 days

  India | October 19, 2022 20:50 IST

  Maharashtra reports XBB sub-variant of Omicron: As per the primary information, all these cases are mild. It said 15 out of these 20 cases (18 of XBB and one each of BQ.1 and BA.2.3.20) were vaccinated against COVID-19 while information on the rest five cases is to be received.

• 

  COVID-19: New 'highly infectious' variants emerge in China

  World | October 12, 2022 13:42 IST

  China lockdown: Meanwhile, holiday spending during China's Golden Week has plunged to its lowest level in seven years, as broad Covid curbs discouraged people from travelling or spending, while a darkening economic outlook continues to erode consumer confidence.

• 

  COVID-19: France approves Omicron-adapted vaccines for booster shot

  World | September 21, 2022 8:03 IST

  COVID-19: According to HAS, the three vaccines approved include those of Moderna and of Pfizer/BioNTech targetting the Omicron variant BA.1, and that of Pfizer/BioNTech adapted for the BA.4 and BA.5 Omicron subvariants, Xinhua news agency reported.

• 

  Vaccinated people infected by Omicron have four times greater protection

  Health | September 08, 2022 6:52 IST

  The study demonstrates that previous infection in vaccinated people continues to confer for the variants that are known for their ability to evade the immune response, such as the subvariant currently dominant.

• 

  Omicron infections provide protection against new COVID-19 variants, says study

  Health | September 01, 2022 23:48 IST

  The study indicates that previous infection in vaccinated people (the so-called hybrid immunity) continues to confer immunity for the variants that are known for their ability to evade the immune response.

• 

  COVID: Reinfection with Omicron more common than thought, reveals study

  Health | August 18, 2022 7:46 IST

  COVID: While Omicron reinfections among older individuals were fewer, the rate was highest (475 of 3,136 individuals [15.1 per cent]) among those aged 18 to 29 years, the researchers said.

• 

  Covid 19: Omicron, its sub-lineages circulating predominantly in India, say sources

  India | August 06, 2022 14:50 IST

  Covid 19 cases: According to the bulletin issued on July 11 by INSACOG, Omicron and its sublineages continue to be the dominant variant in India.

• 

  New Covid Omicron sub-variant found in India? Here's what WHO says

  India | July 07, 2022 11:17 IST

  Covid 19 Omicron Sub Variant: WHO Chief Scientist Soumya Swaminathan said that there has been an emergence of a sub-variant that is being called the BA.2.75.

• 

  New Omicron sub-variants better at evading vaccine and antibody treatments, reveals study

  Health | July 06, 2022 13:20 IST

  In addition, the scientists tested the ability of 19 monoclonal antibody treatments to neutralise the variants and found that only one of the available antibody treatments remained highly effective against both Omicron sub-variants BA.2.12.1 and BA.4/5.